Dr. Noah Federman, M.D.
Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)
10833 Le Conte Ave, Department Of Pediatric Hematology/oncology Ucla
Los Angeles, CA 90095
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
At a glance
- Medical school
- Icahn School of Medicine at Mount Sinai (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2007
Licensed in California since 2004, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: Icahn School of Medicine at Mount Sinai
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Hematology & Oncology Physician primary
CA license A87474 (first issued 2004; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- UC Regents (93 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 3 companies reported 57 payments worth $67,816 in total to this clinician.
| Springworks Therapeutics, Inc. | $49,759 |
|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $11,837 |
| Lantheus Medical Imaging, Inc. | $6,221 |
| Compensation for services other than consulting (speaking, faculty) | $47,617 |
|---|---|
| Consulting Fee | $12,255 |
| Travel and Lodging | $6,966 |
| Food and Beverage | $978 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Springworks Therapeutics, Inc. Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Lantheus Medical Imaging, Inc. May 15, 2025 | Consulting Fee | $6,000 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) Vitrakvi · Oncology | $4,953 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 19, 2025 | Consulting Fee Vitrakvi · Oncology | $3,048 |
| Springworks Therapeutics, Inc. Jul 10, 2025 | Consulting Fee OGSIVEO · DESMOID TUMORS | $2,125 |
All 47 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. Nov 19, 2025 | Consulting Fee Vitrakvi · Oncology | $3,048 |
| Springworks Therapeutics, Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. Sep 24, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to LEAWOOD, KS | $197 |
| Springworks Therapeutics, Inc. Sep 24, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to LEAWOOD, KS | $69.00 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) Vitrakvi · Oncology | $1,524 |
| Springworks Therapeutics, Inc. Sep 11, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to LEAWOOD, KS · in-kind | $351 |
| Springworks Therapeutics, Inc. Sep 11, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to LEAWOOD, KS · in-kind | $254 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 22, 2025 | Consulting Fee | $1,082 |
| Springworks Therapeutics, Inc. Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. Jul 29, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to NEW ORLEANS, LA | $120 |
| Springworks Therapeutics, Inc. Jul 29, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CLAYTON, MO | $120 |
| Springworks Therapeutics, Inc. Jul 29, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to NEW ORLEANS, LA | $96.21 |
| Springworks Therapeutics, Inc. Jul 29, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CLAYTON, MO | $69.23 |
| Springworks Therapeutics, Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. Jul 19, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to NEW ORLEANS, LA · in-kind | $415 |
| Springworks Therapeutics, Inc. Jul 19, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to NEW ORLEANS, LA · in-kind | $209 |
| Springworks Therapeutics, Inc. Jul 15, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CLAYTON, MO · in-kind | $490 |
| Springworks Therapeutics, Inc. Jul 15, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CLAYTON, MO · in-kind | $163 |
| Springworks Therapeutics, Inc. Jul 10, 2025 | Consulting Fee OGSIVEO · DESMOID TUMORS | $2,125 |
| Springworks Therapeutics, Inc. Jun 18, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CHICAGO, IL | $373 |
| Springworks Therapeutics, Inc. Jun 18, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CHICAGO, IL | $110 |
| Springworks Therapeutics, Inc. Jun 18, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CHICAGO, IL | $75.76 |
| Springworks Therapeutics, Inc. Jun 18, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CHICAGO, IL | $71.94 |
| Springworks Therapeutics, Inc. Jun 18, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CHICAGO, IL | $35.74 |
| Springworks Therapeutics, Inc. Jun 18, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CHICAGO, IL | $35.47 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 13, 2025 | Travel and Lodging Vitrakvi · Oncology · travel to Palm Desert, CA · in-kind | $209 |
| Springworks Therapeutics, Inc. Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) Vitrakvi · Oncology | $4,953 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging Vitrakvi · Oncology · travel to Palm Desert, CA · in-kind | $136 |
| Springworks Therapeutics, Inc. Jun 2, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to CHICAGO, IL · in-kind | $757 |
| Springworks Therapeutics, Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. May 21, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to SEATTLE, WA | $120 |
| Springworks Therapeutics, Inc. May 21, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to SEATTLE, WA | $77.91 |
| Springworks Therapeutics, Inc. May 21, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to SEATTLE, WA | $59.93 |
| Lantheus Medical Imaging, Inc. May 15, 2025 | Consulting Fee | $6,000 |
| Springworks Therapeutics, Inc. May 8, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to SEATTLE, WA · in-kind | $366 |
| Springworks Therapeutics, Inc. May 8, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to SEATTLE, WA · in-kind | $277 |
| Springworks Therapeutics, Inc. Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $6,588 |
| Springworks Therapeutics, Inc. Apr 16, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to BALTIMORE, MD | $633 |
| Springworks Therapeutics, Inc. Apr 16, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to BALTIMORE, MD | $120 |
| Springworks Therapeutics, Inc. Apr 16, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to BALTIMORE, MD | $70.26 |
| Springworks Therapeutics, Inc. Apr 16, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to BALTIMORE, MD | $49.38 |
| Springworks Therapeutics, Inc. Apr 16, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to BALTIMORE, MD | $16.60 |
| Springworks Therapeutics, Inc. Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) OGSIVEO · DESMOID TUMORS | $850 |
| Springworks Therapeutics, Inc. Apr 2, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to BALTIMORE, MD · in-kind | $533 |
| Springworks Therapeutics, Inc. Apr 2, 2025 | Travel and Lodging OGSIVEO · DESMOID TUMORS · travel to BALTIMORE, MD · in-kind | $285 |
| Bayer HealthCare Pharmaceuticals Inc. Feb 7, 2025 | Compensation for services other than consulting (speaking, faculty) Vitrakvi · Oncology | $762 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $208,476 in research payments for these studies, mostly to the institutions running them.
- Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Aadi Bioscience, Inc. · Completed · NCT05103358 - A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Regeneron Pharmaceuticals, Inc. · Recruiting · NCT06379789 - NIR-DT-301
Springworks Therapeutics, Inc. - A Phase I Open-label Parallel Group Study to Investigate Olaparib Safety and Tolerability Efficacy and Pharmacokinetics in Paediatric Patients aged 6 months to 17 years with Solid Tumours
AstraZeneca UK Limited
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.